Related Experiment Video
Updated: Sep 26, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Culturally Adapted Floor-to-Stand Exercises for COPD: A Quasi-Experimental Study
Redouene Sid Ahmed Benazzouz1, Massinissa Benyagoub1, Hanane Meriem Fatmi1
1Faculty of Medicine, Amar Telidji University of Laghouat, Laghouat, Algeria.
Objective:
Conventional pulmonary rehabilitation remains difficult to access in many low-resource settings because of practical, geographic, and sociocultural barriers. Accordingly, floor-to-stand exercises (FSE) were developed as an equipment-free program centered on repeated floor-to-stand transitions that are commonly performed in daily life in North Africa. The main objective of the present study was to estimate program completion rates, identify predictors of non-completion, and describe clinical, functional, and peripheral muscle outcomes in chronic obstructive pulmonary disease (COPD) outpatients with documented difficulty rising from the floor.
Material And Methods:
In this prospective, quasi-experimental pilot study, COPD outpatients participated in the 9-week progressive FSE program. Completion was defined as ≥22 floor-to-stand transitions/day during weeks 7-9. Assessments were performed at baseline and at day 63, and outcomes were compared between completers and non-completers.
Results:
Fifteen COPD outpatients were included; the completion rate was 46.7% (7/15). Completers had lower baseline Borg CR10 scores (6.0 vs. 7.5; P = 0.047) and higher 6-minute walk distance (330 vs. 261 m; P = 0.037). On day 63, completers improved on the modified Medical Research Council Dyspnea Scale (-2.0; P = 0.015), Borg CR10 (-3.0; P = 0.011), and COPD assessment test (-8.0; P = 0.008), whereas non-completers improved only on the Borg CR10 (-2.0; P = 0.020). Functional tests and peripheral muscle outcomes showed no consistent changes overall.
Conclusion:
The FSE was feasible and safe in this study, with improvements primarily in symptoms and disease impact. Larger controlled studies are needed to confirm the effectiveness and optimize adherence. Trial registration: ClinicalTrials.gov NCT07277855.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
